Clinical Trial Update: A Study of ATH-1017 in Mild to Moderate Alzheimer's Disease [Phase 2]

View source ↗

Summary

Phase 2 trial update for ATH-1017 in mild to moderate Alzheimer's disease has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Dementia of Alzheimer Type

Drugs mentioned

• ATH-1017

Snippet

Sponsor: LeonaBio | Conditions: Alzheimer Disease, Dementia of Alzheimer Type | Phase 2 | Status: COMPLETED | Results posted: 2023-06-12